These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 17146547)

  • 1. [Secondary prevention of stroke].
    Ringleb P; Hacke W
    Hamostaseologie; 2006 Nov; 26(4):334-42; quiz 343-4. PubMed ID: 17146547
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Stroke: acute treatments and secondary prevention].
    Leys D; Cordonnier C
    Med Sci (Paris); 2009; 25(8-9):733-8. PubMed ID: 19765388
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combination antiplatelet agents for secondary prevention of ischemic stroke.
    Vande Griend JP; Saseen JJ
    Pharmacotherapy; 2008 Oct; 28(10):1233-42. PubMed ID: 18823219
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevention of secondary stroke and transient ischaemic attack with antiplatelet therapy: the role of the primary care physician [corrected].
    Kirshner HS
    Int J Clin Pract; 2007 Oct; 61(10):1739-48. PubMed ID: 17877660
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic interventions for prevention of recurrent ischemic stroke.
    Kirshner HS
    Am J Manag Care; 2008 Jun; 14(6 Suppl 2):S212-26. PubMed ID: 18611103
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiplatelet therapy for the prevention of recurrent stroke and other serious vascular events: a review of the clinical trial data and guidelines.
    Hankey GJ
    Curr Med Res Opin; 2007 Jun; 23(6):1453-62. PubMed ID: 17559741
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiplatelet profiles of the fixed-dose combination of extended-release dipyridamole and low-dose aspirin compared with clopidogrel with or without aspirin in patients with type 2 diabetes and a history of transient ischemic attack: a randomized, single-blind, 30-day trial.
    Serebruany VL; Malinin AI; Pokov AN; Hanley DF
    Clin Ther; 2008 Feb; 30(2):249-59. PubMed ID: 18343263
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiplatelet agents and randomized trials.
    Diener HC
    Rev Neurol Dis; 2007; 4(4):177-83. PubMed ID: 18195669
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Medical prevention of stroke and stroke recurrence in patients with TIA and minor stroke.
    Weber R; Weimar C; Diener HC
    Expert Opin Pharmacother; 2009 Aug; 10(12):1883-94. PubMed ID: 19558342
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Secondary stroke prevention with antiplatelet drugs: have we reached the ceiling?
    Diener HC
    Int J Stroke; 2006 Feb; 1(1):4-8. PubMed ID: 18706062
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clopidogrel for the secondary prevention of stroke.
    Diener HC; Ringleb PA; Savi P
    Expert Opin Pharmacother; 2005 May; 6(5):755-64. PubMed ID: 15934902
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Secondary prevention of stroke.
    MacWalter RS
    Thromb Haemost; 1999 Sep; 82 Suppl 1():95-103. PubMed ID: 10695496
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [No role for oral anticoagulants (target INR: 2.0-3.0) after transient ischaemic attack or cerebral infarction of arterial origin; the 'European/Australasian stroke prevention in reversible ischaemia trial' (ESPRIT)].
    De Schryver EL; Halkes PH
    Ned Tijdschr Geneeskd; 2008 Feb; 152(8):445-53. PubMed ID: 18361194
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anticoagulants, aspirin and dipyridamole in the secondary prevention of cerebral ischaemia: which is the best for which patient?
    Halkes PH; Algra A
    Cerebrovasc Dis; 2007; 24 Suppl 1():107-11. PubMed ID: 17971645
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The emergency department: first line of defense in preventing secondary stroke.
    Ovbiagele B
    Acad Emerg Med; 2006 Feb; 13(2):215-22. PubMed ID: 16436789
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevention of recurrent ischemic stroke.
    Dickerson LM; Carek PJ; Quattlebaum RG
    Am Fam Physician; 2007 Aug; 76(3):382-8. PubMed ID: 17708138
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prediction and prevention of stroke in patients with symptomatic carotid stenosis: the high-risk period and the high-risk patient.
    Rothwell PM
    Eur J Vasc Endovasc Surg; 2008 Mar; 35(3):255-63. PubMed ID: 18178114
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differentiating ischemic stroke subtypes: risk factors and secondary prevention.
    Kirshner HS
    J Neurol Sci; 2009 Apr; 279(1-2):1-8. PubMed ID: 19185319
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Network meta-analysis: simultaneous meta-analysis of common antiplatelet regimens after transient ischaemic attack or stroke.
    Thijs V; Lemmens R; Fieuws S
    Eur Heart J; 2008 May; 29(9):1086-92. PubMed ID: 18349026
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk factor profile and management of cerebrovascular patients in the REACH Registry.
    Röther J; Alberts MJ; Touzé E; Mas JL; Hill MD; Michel P; Bhatt DL; Aichner FT; Goto S; Matsumoto M; Ohman EM; Okada Y; Uchiyama S; D'Agostino R; Hirsch AT; Wilson PW; Steg PG;
    Cerebrovasc Dis; 2008; 25(4):366-74. PubMed ID: 18337635
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.